Universal Starch-Chem Allied Share Price
205.95+6.70 (+3.36%)
+41.06% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
Share Price Live Stats
No results found
Share Market Cap & Key Ratios Overview
No results found
About
No results found
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
No results found
Universal Starch-Chem Allied Share Price
205.95+6.70 (+3.36%)
+41.06% past 1 Year
Financial overview
Peer Comparison
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Cash Flow
Consolidated
Standalone
₹
%
Fundamental Ratios
Consolidated
Standalone
Universal Starch-Chem Allied Share Price
205.95+6.70 (+3.36%)
+41.06% past 1 Year
Technical meters
No results found
Pivot
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Universal Starch-Chem Allied Share Price
205.95+6.70 (+3.36%)
+41.06% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
No results found
Bulk & block deals
No results found
Insider trading & SAST
No results found
Universal Starch-Chem Allied Share Price
205.95+6.70 (+3.36%)
+41.06% past 1 Year
Corporate Actions
Date
Type
Details
Company details
Universal Starch-Chem Allied Share Price
205.95+6.70 (+3.36%)
+41.06% past 1 Year
Corporate filings & documents
No corporate filings & documents found
Universal Starch-Chem Allied Share Price
205.95+6.70 (+3.36%)
+41.06% past 1 Year
News
NSE Index Closes Lower As Broader Market Faces Selling Pressure
Broader Market
Theleela Reports Higher Q2 EBITDA Despite Margin Compression
Equity
THELEELA
Theleela Reports Strong Second Quarter Revenue Growth Year On Year
Equity
THELEELA
Theleela Q2 EBITDA Rises While Margin Declines Year On Year
Equity
THELEELA
The Leela Reports Strong Q2 Net Profit Growth Above Estimates
Equity
THELEELA
Hindustan Unilever Reports Rs 124.86 Crores NSE Block Trade
Equity
HINDUNILVR
Abakkus Flexi Cap Fund Reports 1.08 Percent Stake In BEML During Second Quarter
Equity
BEML
Canara Bank anticipates stronger credit growth and improved net interest margins
Equity
CANBK
Centre Proposes Cancer Drug Margin Caps, Pressuring Hospital Oncology Revenues
Equity
Sakar Healthcare Advances Oncology Exports With Marketing Approvals
Equity
SAKAR
Landmark Cars Expects Stronger Second Half On Festive Demand
Equity
LANDMARK
Landmark Cars reports record revenue and expands used car platform partnership
Equity
LANDMARK
BHEL Approves Rs 500 Crore Haridwar Investment, Consolidates Two Facilities
Equity
BHEL
BHEL Q2 Revenue Surpasses Estimates With Strong Yearly Growth
Equity
BHEL
BHEL Reports Strong Q2 EBITDA Growth And Margin Expansion
Equity
BHEL
BHEL Reports Strong Second Quarter Profit Growth Above Analyst Estimates
Equity
BHEL
CAMS Partners With NISM To Strengthen Capital Markets Compliance Learning
Equity
CAMS
HCLTech Reports Rs 70.57 Crores NSE Block Trade Involving 533,964 Shares
Equity
HCLTECH
SEBI Proposes Separating Derivatives Settlement From Cash Closing Prices
Equity
GROWW
Elecon reports higher second quarter EBITDA and improved operating margin
Equity
ELECON